DSGN – design therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones [Yahoo! Finance]
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
Design Therapeutics, Inc. (NASDAQ: DSGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $6.00.
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
Independent Director of Design Therapeutics Picks Up 88% More Stock [Yahoo! Finance]
Form 10-Q Design Therapeutics, For: Mar 31
Form 8-K Design Therapeutics, For: May 08
Form ARS Design Therapeutics, For: Dec 31
Form DEFA14A Design Therapeutics,
Form DEF 14A Design Therapeutics, For: Jun 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.